Tag Archives: U.S.

Albireo’s rare liver disease drug Bylvay scores back-to-back approvals in U.S., Europe

With a pair of approvals on both sides of the Atlantic, liver disease-focused biotech Albireo is off and running with its new medicine Bylvay. The oral drug, the first treatment for pruritus in patients with progressive familial intrahepatic cholestasis (PFIC), scored an FDA nod Tuesday and a European approval Monday. With the FDA’s blessing, Albireo is kicking off an “immediate”… Read More »

Canadian firm works with controversial U.S. company to make ‘better’ COVID vaccine, but says Ottawa not interested

Breadcrumb Trail Links World Reopening Canada PostPandemic News National More Reopening Canada Health and Wellness Health Canadian Politics Canada ‘So far, the Canadian government hasn’t shown an inclination to talk to us about purchasing Canadian,” said Brad Sorenson, CEO of Providence Therapeutics Author of the article: Tom Blackwell Publishing date: May 25, 2021  •  1 day… Read More »

U.S. FDA Approves ALK’s Ragwitek (Short Ragweed Pollen Allergen Extract) Tablet for Sublingual Use as Immunotherapy for Children and Adolescents With Short Ragweed Pollen-Induced Allergic Rhinitis With or Without Conjunctivitis

ROUND ROCK, Texas, April 19, 2021 /PRNewswire/ — ALK (ALKB: DC / OMX: ALK B / AKABY / AKBLF), a global, research-driven pharmaceutical company that focuses on the diagnosis and treatment of allergies, announced that the U.S. Food and Drug Administration (FDA) approved Ragwitek (Short Ragweed Pollen Allergen Extract) Tablet for Sublingual Use for the… Read More »

Study Finds Growing Acceptance of COVID Vaccine by U.S. Health Care Workers

TUESDAY, March 23, 2021 — Health care workers were just as uneasy as everyone else when COVID-19 vaccines were about to be approved in the United States, with large numbers hesitant to take the shot in early December, a new study reveals. But that hesitancy dwindled over the next few weeks, as health system employees… Read More »

Covid vaccine skepticism will prevent U.S. from reaching normalcy, ICU doctor says

A new poll found that 49% of Republican men said they won’t get vaccinated for Covid-19 and Dr. Vin Gupta said that “will determine the trajectory of this pandemic” to the detriment of all Americans. “All forecasts right now say that we’re going to be past the worst of this with normalcy by say end… Read More »